Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.

Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI.

Eur Psychiatry. 2012 Oct;27(7):518-21. doi: 10.1016/j.eurpsy.2011.03.006. Epub 2011 Jun 12.

PMID:
21665441
2.

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.

Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI.

J Affect Disord. 2012 Feb;136(3):1174-8. doi: 10.1016/j.jad.2011.04.059. Epub 2011 Sep 10.

PMID:
21911258
3.

S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.

Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M.

Am J Psychiatry. 2010 Aug;167(8):942-8. doi: 10.1176/appi.ajp.2009.09081198. Epub 2010 Jul 1.

PMID:
20595412
4.

Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery.

Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Abarca JE, Herrera-Guzmán D, Montelongo-Pedraza P, Padrós Blázquez F, Peró-Cebollero M, Guàrdia-Olmos J.

J Affect Disord. 2010 Jun;123(1-3):341-50. doi: 10.1016/j.jad.2009.10.009. Epub 2009 Nov 6.

PMID:
19896719
5.

Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants.

Nagane A, Baba H, Nakano Y, Maeshima H, Hukatsu M, Ozawa K, Suzuki T, Arai H.

Psychiatry Res. 2014 Aug 15;218(1-2):101-5. doi: 10.1016/j.psychres.2014.04.013. Epub 2014 Apr 16.

PMID:
24768252
6.

Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder.

Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Guzmán D, Guàrdia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE.

J Psychiatr Res. 2009 Jun;43(9):855-63. doi: 10.1016/j.jpsychires.2008.10.015. Epub 2009 Jan 6.

PMID:
19128810
8.

Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.

Ferguson JM, Wesnes KA, Schwartz GE.

Int Clin Psychopharmacol. 2003 Jan;18(1):9-14.

PMID:
12490769
9.

Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

Herrera-Guzmán I, Herrera-Abarca JE, Gudayol-Ferré E, Herrera-Guzmán D, Gómez-Carbajal L, Peña-Olvira M, Villuendas-González E, Joan GO.

Psychiatry Res. 2010 May 30;177(3):323-9. doi: 10.1016/j.psychres.2010.03.006. Epub 2010 Apr 10.

PMID:
20385412
10.
11.

S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response.

Sarris J, Papakostas GI, Vitolo O, Fava M, Mischoulon D.

J Affect Disord. 2014 Aug;164:76-81. doi: 10.1016/j.jad.2014.03.041. Epub 2014 Apr 1.

PMID:
24856557
12.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

13.

The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder.

Rothschild AJ, Raskin J, Wang CN, Marangell LB, Fava M.

Compr Psychiatry. 2014 Jan;55(1):1-10. doi: 10.1016/j.comppsych.2013.08.008. Epub 2013 Oct 24.

PMID:
24268564
14.

SAMe and sexual functioning.

Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI.

Eur Psychiatry. 2012 Aug;27(6):451-4. doi: 10.1016/j.eurpsy.2011.01.003. Epub 2011 Mar 12.

PMID:
21398094
15.

Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study.

Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, Otte C.

Psychoneuroendocrinology. 2012 May;37(5):685-92. doi: 10.1016/j.psyneuen.2011.08.012. Epub 2011 Sep 23.

PMID:
21944955
16.

Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.

Castellano S, Ventimiglia A, Salomone S, Ventimiglia A, De Vivo S, Signorelli MS, Bellelli E, Santagati M, Cantarella RA, Fazio E, Aguglia E, Drago F, Di Nuovo S, Caraci F.

CNS Neurol Disord Drug Targets. 2016;15(10):1290-1298.

PMID:
27712575
17.

Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.

Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ.

J Clin Psychiatry. 2006 Feb;67(2):240-6.

PMID:
16566619
18.

A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.

Fava M, Graves LM, Benazzi F, Scalia MJ, Iosifescu DV, Alpert JE, Papakostas GI.

J Clin Psychiatry. 2006 Nov;67(11):1754-9.

PMID:
17196056
19.

Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: an exploratory study.

Alves TC, Rays J, Telles RM, Júnior RF, Wajngarten M, Romano BW, Watanabe C, Busatto GF.

Psychosomatics. 2007 Jan-Feb;48(1):22-30.

PMID:
17209146

Supplemental Content

Support Center